Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 296 (RN7SKP296) is annotated as a pseudogene of the non-coding RNA gene RN7SK. The functional RN7SK gene encodes the 7SK small nuclear RNA, an abundant non-coding RNA central to the regulation of transcription elongation by acting as a scaffold for the 7SK small nuclear ribonucleoprotein (snRNP) complex[1][3][4]. 7SK snRNA regulates the activity of positive transcription elongation factor b (P-TEFb), influencing transcriptional control, cell cycle, and differentiation[2][3][4][5][6]. However, pseudogenes such as RN7SKP296 typically lack transcriptional activity and function, and there is no evidence of their involvement in known biological processes or disease. RN7SKP296 is not considered a therapeutic target nor a functionally relevant molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 296 (RN7SKP296).